Home

Eccentrico Raccontare Abituale clinical breakpoints Proposta alternativa fatturabile Specialità

Standardization of Veterinary Susceptibility Testing
Standardization of Veterinary Susceptibility Testing

AST, MIC, Clinical Breakpoints, ECOFFs and AST QC | Microbiology and  Infectious Diseases postgraduate teaching (PRIDA)
AST, MIC, Clinical Breakpoints, ECOFFs and AST QC | Microbiology and Infectious Diseases postgraduate teaching (PRIDA)

Identifying breakpoints: normal MIC distribution. Figure 2. Impact of... |  Download Scientific Diagram
Identifying breakpoints: normal MIC distribution. Figure 2. Impact of... | Download Scientific Diagram

Frontiers | En Route towards European Clinical Breakpoints for Veterinary  Antimicrobial Susceptibility Testing: A Position Paper Explaining the  VetCAST Approach | Microbiology
Frontiers | En Route towards European Clinical Breakpoints for Veterinary Antimicrobial Susceptibility Testing: A Position Paper Explaining the VetCAST Approach | Microbiology

Frontiers | En Route towards European Clinical Breakpoints for Veterinary  Antimicrobial Susceptibility Testing: A Position Paper Explaining the  VetCAST Approach | Microbiology
Frontiers | En Route towards European Clinical Breakpoints for Veterinary Antimicrobial Susceptibility Testing: A Position Paper Explaining the VetCAST Approach | Microbiology

Free Resources
Free Resources

Clinical breakpoints according to EUCAST 1 . | Download Table
Clinical breakpoints according to EUCAST 1 . | Download Table

Epidemiological Cutoff Values: a Micro-Comic Strip | Journal of Clinical  Microbiology
Epidemiological Cutoff Values: a Micro-Comic Strip | Journal of Clinical Microbiology

JoF | Free Full-Text | A Pragmatic Approach to Susceptibility  Classification of Yeasts without EUCAST Clinical Breakpoints
JoF | Free Full-Text | A Pragmatic Approach to Susceptibility Classification of Yeasts without EUCAST Clinical Breakpoints

Linezolid Rationale for the EUCAST clinical breakpoints, version 1.0 ...
Linezolid Rationale for the EUCAST clinical breakpoints, version 1.0 ...

Validation of Antibiotic Susceptibility Testing Guidelines in a Routine  Clinical Microbiology Laboratory Exemplifies General Key Challenges in  Setting Clinical Breakpoints | Antimicrobial Agents and Chemotherapy
Validation of Antibiotic Susceptibility Testing Guidelines in a Routine Clinical Microbiology Laboratory Exemplifies General Key Challenges in Setting Clinical Breakpoints | Antimicrobial Agents and Chemotherapy

Tentative clinical breakpoints and epidemiological cut-off values of  nemonoxacin for Streptococcus pneumoniae and Staphylococcus aureus isolates  associated with community-acquired pneumonia - ScienceDirect
Tentative clinical breakpoints and epidemiological cut-off values of nemonoxacin for Streptococcus pneumoniae and Staphylococcus aureus isolates associated with community-acquired pneumonia - ScienceDirect

The Clinical & Laboratory Standards Institute announces clinical breakpoints  for azithromycin for Shigella | NARMS | CDC
The Clinical & Laboratory Standards Institute announces clinical breakpoints for azithromycin for Shigella | NARMS | CDC

Clinical breakpoints and epidemiological cut-off. | Download Scientific  Diagram
Clinical breakpoints and epidemiological cut-off. | Download Scientific Diagram

Updating Breakpoints in Antimicrobial Susceptibility Testing
Updating Breakpoints in Antimicrobial Susceptibility Testing

Epidemiologic Cutoff Value
Epidemiologic Cutoff Value

Frontiers | En Route towards European Clinical Breakpoints for Veterinary  Antimicrobial Susceptibility Testing: A Position Paper Explaining the  VetCAST Approach | Microbiology
Frontiers | En Route towards European Clinical Breakpoints for Veterinary Antimicrobial Susceptibility Testing: A Position Paper Explaining the VetCAST Approach | Microbiology

EUCAST Clinical Breakpoints for Pseudomonas spp. | Download Table
EUCAST Clinical Breakpoints for Pseudomonas spp. | Download Table

How to interpret MICs of antifungal compounds according to the revised clinical  breakpoints v. 10.0 European committee on antimicrobial susceptibility  testing (EUCAST) - Clinical Microbiology and Infection
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST) - Clinical Microbiology and Infection

JoF | Free Full-Text | Updated EUCAST Clinical Breakpoints against  Aspergillus, Implications for the Clinical Microbiology Laboratory | HTML
JoF | Free Full-Text | Updated EUCAST Clinical Breakpoints against Aspergillus, Implications for the Clinical Microbiology Laboratory | HTML

Clinical breakpoints and epidemiologic cutoff values for Candida... |  Download Scientific Diagram
Clinical breakpoints and epidemiologic cutoff values for Candida... | Download Scientific Diagram

The role of pharmacokinetics/pharmacodynamics in setting clinical MIC  breakpoints: the EUCAST approach - Clinical Microbiology and Infection
The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach - Clinical Microbiology and Infection